Induction of cell cycle arrest and β cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6

Immunity

Volumn 6, Issue 1, 1997, Pages 47-56

  Morse, Leslie ^a   Chen, Dongquan ^a,b   Franklin, David ^c   Xiong, Yue ^c   Chen Kiang, Selina ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; IMMUNOGLOBULIN M; INTERLEUKIN 6;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE DIFFERENTIATION; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030891628     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80241-1     Document Type: Article

References (38)

1. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., Liu, Y.J. and Saeland, R.S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
2. Chen, P.-L., Reiley, D.J., Chen-Kiang, S., and Lee, W.-H. (1996). Retinoblastoma protein directly interacts with and activates the transcripiton factor NF-IL6 upon induction of cellular differentiation. Proc. Natl. Acad. Sci. USA 93, 465-469.
3. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y., and Wang, X.-F. (1995). Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92, 5545-5549.
4. Deng, C., Zhang, P., Harper, J.W., Elledge, S.J., and Leder, P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
5. EI-Diery, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trant, J.M., Lin, D., Mercer, W.E., Kinaier, K.W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
6. INK4c and its preodminant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell 7, 1587-1599.
7. Goodrich, D.W., Wang, N.P., Qian, Y.-W., Lee, E.Y.-H.P., and Lee, W.-H. (1991). The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67, 293-302.
8. Guan, K.-L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X., O'keefe, C.L., Matera, A.G., and Xiong, Y. (1994). Growth suppression by p18, a p16INK4/MTS1 and p14 INK4B/MTS2-related CKD inhibitor, correlates with Wild-type pRb function. Genes Dev. 8, 2939-2952.
9. Halevy, O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A.B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021.
10. Hardy, R., and Reynolds, R. (1991). Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 111, 1061-1080.
11. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1-cyclin-dependent kinases. Cell 75, 805-816.
12. Hilbert, D.M., Kopf, M., Mock, B.A., Kohler, G., and Rudikoff, S. (1995). Interleukin 6 is essential for in vivo development of B-lineage neoplasms. J. Exp. Med. 182, 243-248.
13. Hirai, H., Roussel, M., Kato, J.-Y., Ashmun, R., and Sherr, C.J. (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672-2681.
14. Hsu, W., Kerppola, T.K., Chen, P.-L., Curran, T., and Chen-Kiang, S. (1994). Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol. Cell. Biol. 14, 268-276.
15. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E., and Sherr, C.J. (1993). Direct binding of cyclin D to the retinoblastoma gene product and pRb phosporylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 1993.
16. Kempkes, B., Spitkovsky, D., Jansen-Durr, P., Ellwart, J.W., Kremer, E., Delecluse, H.-J., Rottenberger, C., Bornkamm, G.W., and Hammerschmidt, W. (1995). B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barrvirus mutants conditional for EBNA2. EMBO J. 14, 88-96.
17. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zindernagel, R., Bluethmann, H., and Kohler, G. (1994). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.
18. Lee, E.Y.H.P., Chang, C.-Y., Hu, N., Wang, Y.-C., Lai, C.-C., Herrup, K., Lee, W.-H., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
19. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J., and Kato, J.-Y. (1994). D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066-2076.
20. May, L., Shaw, J.E., Khanna, A.K., Zabriskie, J.B., and Sehgal, P. B. (1991). Marked cell-type-specific differences in glycosylation of human interleukin-6. Cytokine 3, 204-211.
21. Meyerson, M., and Harlow, E. (1994). Identification of G1 kinase activity for cdk6 a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086.
22. Natkunam, Y., Zhang, X., Liu, Z., and Chen-Kiang, S. (1994). Simultaneous activation of immunoglobulin and Oct-2 synthesis and repression of surface MHC class II expression by IL-6. J. Immunol. 153, 3476-3484.
23. Nevins, J.R. (1992). E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
24. Nordan, R., and Potter, M. (1986). A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233, 566-569.
25. Parker, S., Eichele, G., Zhang, P., Rawls, A., Sands, A.T., Bradley, A., Olson, E.N., Harper, W., and Elledge, S.J. (1995). p53-independent expression of p21cip1 in muscle and other terminally differentiation cells. Science 267, 1024-1027.
26. Paul, W., and Seder, R.A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
27. Raynal, M.-C., Liu, Z., Hirano, T., Mayer, L., Kishimoto, T., and Chen-Kiang, S. (1989). Interleukin-6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. Proc. Natl. Acad. Sci. USA 86, 8024-8028.
28. Schindler, C., and Darnell, J.E. (1995). Tanscriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651.
29. Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
30. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9, 1149-1163.
31. Singh, P., Coe, J., and Hong, W. (1995). A role for retinoblastoma protein in potentiating transcriptional activtion by the glucocorticoid receptor. Nature 374, 562-566.
32. Spruck, C.H., Gonzales-Zulueta, M., Shibata, A., Simoneau, A.R., Lin, M.-F., Gonzales, F., Tsai, Y.C., and Jones, P.A. (1994). p16 in uncultured tumors. Nature 370, 183-184.
33. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A., and El-Houseini, M.E. (1994). Induction of p21(WAF1/CIP1) during differentiation. Oncogene 9, 3389-3396.
34. Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J.-I., Yamamura, K.-I., Hirano, T., and Kishimoto, T. (1989). IgG1 plasmacytosis in interleukin-6 transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7547-7551.
35. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J.-I., Yamamura, K.-I., Hirano, T., and Kishimoto, T. (1992). Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin-6 transgenic mice. Proc. Natl. Acad. Sci. USA 89, 232-235.
36. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
37. Xiong, Y., Zhang, H., and Beach, D. (1992). D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514.
38. Zhang, X., Blenis, J., Li, H.-C., Schindler, C., and Chen-Kiang, S. (1995). Requirement of serine phosphorylation for the formation of Stat-promoter complexes. Science 267, 1990-1994.